These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7400077)

  • 1. Susceptibility of nosocomial Acinetobacter anitratus strains to 13 antibiotics.
    Daschner F; Nopper S
    J Antimicrob Chemother; 1980 May; 6(3):415-6. PubMed ID: 7400077
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibacterial activity of aminoglycosides against nosocomial strains of Acinetobacter baumannii isolated between 1990 and 1999].
    González G; Ramírez C; Muñoz M
    Rev Esp Quimioter; 2000 Dec; 13(4):401-4. PubMed ID: 11498707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concerning the sensitivity of Acinetobacter calcoaceticus.
    Jedlicková Z; Tesaríková E; Výmola F
    J Hyg Epidemiol Microbiol Immunol; 1990; 34(1):73-6. PubMed ID: 2351822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The susceptibility to tigecycline of Acinetobacter spp. may vary depending on the methodology used.
    Zárate MS; Serruto G; Smayevsky J
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e351-2. PubMed ID: 20031463
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antibiotic resistance patterns in Acinetobacter spp. strains isolated from hospital environment].
    Văduva DB; Muntean D; Lonescu G; Licker M; Văduva MB; Velimirovici D; Rădulescu M; Dumitraşcu V; Crăciunescu M; Dugăeşescu D; Horhat F; Piluţ C; Bădiţoiu L; Moldovan R
    Bacteriol Virusol Parazitol Epidemiol; 2008; 53(2):103-7. PubMed ID: 19856849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-test minimum inhibitory concentrations for tigecycline against nosocomial Acinetobacter baumannii strains.
    Akcam FZ; Kaya O; Basoglu N; Avsar K; Yayli G
    J Chemother; 2007 Apr; 19(2):230-1. PubMed ID: 17434835
    [No Abstract]   [Full Text] [Related]  

  • 7. In-vitro and in-vivo activities of antimicrobial agents against Acinetobacter calcoaceticus.
    Obana Y; Nishino T; Tanino T
    J Antimicrob Chemother; 1985 Apr; 15(4):441-8. PubMed ID: 4008377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter.
    Espinal P; Roca I; Vila J
    Future Microbiol; 2011 May; 6(5):495-511. PubMed ID: 21585259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiological study and effect on antimicrobial use in the genus Acinetobacter in a university hospital].
    Iglesias de Sena H; Mirón Canelo JA; Fresnadillo Martínez MJ; Sáenz González MC
    Rev Esp Quimioter; 2004 Jun; 17(2):177-83. PubMed ID: 15470512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug-resistant Acinetobacter: a threat to the antibiotic era.
    Peleg AY; Paterson DL
    Intern Med J; 2006 Aug; 36(8):479-82. PubMed ID: 16866649
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sensitivity of Acinetobacter calcoaceticus-baumanni complex and Acinetobacter lwoffi to common antibiotics].
    Reina J
    Enferm Infecc Microbiol Clin; 1991; 9(7):438-9. PubMed ID: 1799617
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimicrobial susceptibility of Acinetobacter strains identified by DNA-DNA hybridization.
    Tjernberg I
    APMIS; 1990 Apr; 98(4):320-6. PubMed ID: 2354051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An underestimated nosocomial pathogen, Acinetobacter calcoaceticus.
    Bergogne-Berezin E; Joly-Guillou ML
    J Antimicrob Chemother; 1985 Nov; 16(5):535-8. PubMed ID: 4077770
    [No Abstract]   [Full Text] [Related]  

  • 14. Phage-types and susceptibility to 26 antibiotics of nosocomial strains of Acinetobacter isolated in Portugal.
    Santos Ferreira MO; Vieu JF; Klein B
    J Int Med Res; 1984; 12(6):364-8. PubMed ID: 6519351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiogram, biotyping and plasmid profile analysis of Acinetobacter calcoaceticus var. anitratus.
    Teng LJ; Ho SW; Luh KT
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Nov; 21(4):236-42. PubMed ID: 3076859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is sulbactam really the answer for treatment of infections caused by multiresistant strains of Acinetobacter spp.?].
    Casellas JM; Dana R
    Enferm Infecc Microbiol Clin; 1997; 15(6):335-6. PubMed ID: 9376409
    [No Abstract]   [Full Text] [Related]  

  • 17. Previous Antibiotic Exposure and Antimicrobial Resistance Patterns of
    Djordjevic ZM; Folic MM; Jankovic SM
    Balkan Med J; 2017 Dec; 34(6):527-533. PubMed ID: 29215335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Delhi metallo-beta-lactamase-1-producing Acinetobacter spp. infection: report of a survivor.
    Schuelter-Trevisol F; Schmitt GJ; Araújo JM; Souza LB; Nazário JG; Januário RL; Mello RS; Trevisol DJ
    Rev Soc Bras Med Trop; 2016 Feb; 49(1):130-4. PubMed ID: 27163578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
    Zavascki AP; Soares FC; Superti SV; Silbert S; Silva FM; Barth AL
    Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
    [No Abstract]   [Full Text] [Related]  

  • 20. Acinetobacter spp. susceptibility to tigecycline: a worldwide perspective.
    Curcio D; Fernández F
    J Antimicrob Chemother; 2007 Aug; 60(2):449-50. PubMed ID: 17561503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.